Jushi Holdings Announces Certain Unaudited 2020 Fourth Quarter and Full Year 2020 Financial Results Apr 21, 2021
PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Rare Cancers and Infectious Diseases Apr 20, 2021
PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the… Apr 20, 2021
Mindset Pharma Announces Strong Confirmation of In Vivo Proof-of-Concept Across Its Entire New Drug Program Portfolio Apr 20, 2021
